Search
for

    Glossary Dupilumab

    monoclonal antibody treating inflammatory conditions like eczema and asthma

    Dupilumab is a monoclonal antibody medication used to treat certain inflammatory conditions like eczema (atopic dermatitis) and asthma. It works by blocking specific proteins (IL-4 and IL-13) involved in the body's immune response, thereby reducing inflammation and symptoms.

    Research 10 of 446

    1. Dupilumab in Inflammatory Skin Diseases: A Systematic Review Biomolecules · 2023 · 72 citations
    2. Alopecia areata after dupilumab for atopic dermatitis JAAD case reports · 2018 · 53 citations
    3. Dupilumab: A Review of Present Indications and Off-Label Uses Journal of investigational allergology & clinical immunology · 2021 · 50 citations
    4. Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab Journal of Investigational Allergology and Clinical Immunology · 2018 · 49 citations
    5. Drug-induced alopecia after dupilumab therapy JAAD case reports · 2018 · 49 citations
    6. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report Acta Dermato Venereologica · 2019 · 33 citations
    7. Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study The Journal of Dermatology · 2023 · 29 citations
    8. Dupilumab and alopecia: A Janus effect Dermatologic Therapy · 2019 · 29 citations
    9. Alopecia areata in 2 patients treated with dupilumab: New onset and worsening JAAD Case Reports · 2019 · 26 citations
    10. Dupilumab side effect in a patient with atopic dermatitis: a case report study Biologics · 2019 · 25 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →